ANKL is a rare and aggressive type of blood cancer affecting a type of white blood cell called natural killer (NK) cells. In ANKL, the NK cells are abnormal and multiply out of control, crowding out ...
Perseus Proteomics, Inc. ( (JP:4882)) has shared an announcement. Perseus Proteomics, Inc. has announced an extension of the Phase I/II clinical trial period for its anti-transferrin receptor 1 ...
Aggressive NK-cell leukemia (ANKL) results from the systemic neoplastic proliferation of natural killer (NK) cells. ANKL shows an aggressive clinical course with features that overlap with the ...
Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results